Wearables in clinical trials?
Clinical trials are evolving with wearables and digital health technologies, bringing a fundamental shift in how studies are conducted. From better patient monitoring to stronger data integrity, these innovations are transforming trial efficiency.
A 2020 Tufts Center for the Study of Drug Development (Tufts CSDD) survey found that 22% of global Phase 2 and 3 trials incorporated digital health tools, including wearables.
The benefits? Fewer site visits, improved efficiency, and better data collection.
Why Wearables Matter in Clinical Trials?
✅ Continuous, real-time monitoring – Wearables provide 24/7 insights into vitals, activity levels, and medication adherence, reducing dependence on-site visits.
✅ Improved patient compliance – Digital reminders, symptom tracking, and automated alerts enhance engagement and retention.
✅ Stronger data integrity – Objective, real-world evidence reduces recall bias and enhances data accuracy.
The Indian Perspective:
1. Initiatives like Ayushman Bharat Digital Mission (ABDM) are accelerating interoperability and digital adoption in healthcare.
2. More patients and researchers are embracing wearable technology, though regulatory clarity and data security remain key challenges.
3. Digital health tools reduce patient burden and expand access to clinical trials, especially in Tier 2 & 3 cities.
Wearables are not just enhancing clinical trials—they are reshaping the future of patient-centric research. As technology advances, integrating digital health solutions will be key to improving trial efficiency and patient outcomes.
What are the biggest challenges in implementing wearables in clinical trials?
Drop your thoughts in the comments!